Top View
- Dissecting Molecular Genetic Mechanisms of 1Q21.1 CNV in Neuropsychiatric Disorders
- Inhibition of Β-Catenin/B Cell Lymphoma 9 Protein−Protein Interaction Using Α-Helix–Mimicking Sulfono-Γ-Aapeptide Inhibitors
- Role of 1Q21 in Multiple Myeloma: from Pathogenesis to Possible Therapeutic Targets
- Nuclear Regulation of Wnt/-Catenin Signaling
- Analysis and Characterization of Hematologic Cancers Using a Comprehensive NGS Panel Comprised of DNA and RNA Baits Targeting 704 Genes
- Tumour Mutation Load an Assay to Determine Tumour Mutation Burden (TMB) in Solid Tumours
- Transcriptional Regulation of Wnt/Β-Catenin Pathway in Colorectal Cancer
- Dissecting the ß-Catenin-Dependent and -Independent Functions of BCL9 and BCL9-2 in Intestinal Tumorigenesis
- TBX3 Acts As Tissue-Specific Component of the Wnt/B-Catenin
- 1 BCL-3 Enhances Β-Catenin Signalling in Colorectal
- Expanding the Phenotype of Reciprocal 1Q21.1 Deletions and Duplications: a Case Series Martina Busè1* , Helenia C
- Global Gene Expression Changes of in Vitro Stimulated Human Transformed
- KDM2B, an H3K36-Specific Demethylase, Regulates Apoptotic Response of GBM Cells to TRAIL
- Targeting Anti-Apoptotic Bcl-2 Proteins with Scyllatoxin-Based BH3 Domain Mimetics
- The Presence of Two Rare Genomic Syndromes, 1Q21 Deletion and Xq28 Duplication, Segregating Independently in a Family with Intellectual Disability
- Mutations in Bcl9 and Pygo Genes Cause Congenital Heart Defects by Tissue-Specific Perturbation of Wnt/Β-Catenin Signaling
- Targeting MEF2D-Fusion Oncogenic Transcriptional Circuitries in B-Cell Precursor Acute Lymphoblastic Leukemia
- Fluorescence in Situ Hybridization Analysis of Chromosome 1
- Detection of Translocations Affecting the BCL6 Locus in B Cell
- Essential Role of B-Cell Lymphoma-9 in Human Breast Ductal Carcinoma in Situ Progression to Invasive Breast Cancer
- BCL9 Is an Essential Component of Canonical Wnt Signaling That Mediates the Differentiation of Myogenic Progenitors During Muscle Regeneration
- Signature Redacted
- TBX3 Acts As Tissue-Specific Component of the Wnt/Β
- KDM3 Epigenetically Controls Tumorigenic Potentials of Human Colorectal Cancer Stem Cells Through Wnt/B-Catenin Signalling
- Molecular Features of B-Cell Lymphoma Reiner Siebert, MD,* Andreas Rosenwald, MD,† Louis M
- BCL9 Regulates CD226 and CD96 Checkpoints in CD8+ T Cells to Improve PD-1 Response in Cancer
- 1Q21.1 Microduplication Expression in Adults
- Oncology Gene List
- Therapeutic Targeting of Wnt Signaling Beyond Β-Catenin and The
- A Cytoplasmic Role of Wnt/Β-Catenin Transcriptional Cofactors Bcl9, Bcl9l, and Pygopus in Tooth Enamel Formation
- Targeting the BCL9/B9L Binding Interaction with Β-Catenin As a Potential Anticancer Strategy
- The Genetics of Microdeletion and Microduplication Syndromes: an Update
- 1Q21.1 Microdeletion and Microduplication in a Patient with Coarctation of Aorta, Seizure and Dismorphic Features
- Aberrations of Chromosomes 1 and 16 in Breast Cancer: a Framework for Cooperation of Transcriptionally Dysregulated Genes
- Mutations in Bcl9 and Pygo Genes Cause Congenital Heart Defects by Tissue-Specific Perturbation of Wnt/Β-Catenin Signaling
- Positive Gastric Cancer with Sequential Genomic Profiling
- Datasheet A00142-1 Anti-BCL6 Antibody
- Catenin Antagonist BC2059 and Histone Deacetylase Inhibitor Against AML Cells
- TCF7L2 Rs7903146 Gene Variation Is Associated with Risk of Type 2